Often seen as an option of last resort for ventricular tachycardia, new research suggests catheter ablation could have a ...

Discover key insights from Teleflex's Q1 2025 earnings call, including revenue performance, strategic updates, and growth outlook.

Good morning, ladies and gentlemen, and welcome to the Teleflex First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded, and we ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Teleflex Incorporated resulting from allegations that ...

A system hybridizing cardiac contractility modulation and implantable cardioverter defibrillation successfully converted ...

In the main PRAETORIAN report, the investigators had shown that the subcutaneous ICD matched the transvenous ICD on efficacy ...

The drug-eluting stent market is anticipated to grow at a CAGR of 8.20% from US$11.499 billion in 2025 to US$17.049 billion ...

Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral ...

DelveInsight's Balloon Catheter Market Insights report provides the current and forecast market analysis, individual leading Balloon Catheter Companies market shares, challenges, Balloon Catheter ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE: TFX) ...

The global branched stent graft market has demonstrated robust growth in recent years, and projections indicate continued expansion in the coming decade. With an estimated market value of USD 361 ...